Förderpreis „Neue Immunologische Therapien“ of the DGAKI awarded to Julia Esser-von Bieren

© Sebastian Semmer, Berlin / wikonect GmbH

 

The German Society of Allergology and Clinical Immunology (DGAKI) presents an annual award in the field of "novel immunological therapies", which is sponsored by Sanofi-Aventis GmbH and endowed with 5000 euros. This year, the recipient of the award was PD Dr. Julia Esser-von Bieren, head of the Helmholtz Young Investigator group “Innate Immunomodulation” at ZAUM. The award ceremony took place during the German Allergy Congress in Wiesbaden on September 26 2020. The award is granted for outstanding papers in the field of new immunological therapies against allergic/ atopic diseases and is intended to support promising young scientists. The award was due to a recent publication of the group entitled: “An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products”:

https://stm.sciencemag.org/content/12/540/eaay0605

Photo © Sebastian Semmer, Berlin / wikonect GmbH